Molecular Imaging News and Research

RSS

Detailed performance evaluation of the uEXPLORER total-body PET/CT scanner

A performance evaluation of the uEXPLORER total-body PET/CT scanner showed that it exhibits ultra-high sensitivity that supports excellent spatial resolution and image quality.

8 Jul 2021

Molecular imaging can improve therapeutic management of pancreatic ductal adenocarcinomas

For patients with pancreatic ductal adenocarcinomas (PDAC), molecular imaging can improve staging and clinical management of the disease, according to research published in the June issue of The Journal of Nuclear Medicine.

7 Jul 2021

New PET imaging method tracks immunotherapeutic efficacy in mouse models

Several cancer tumors grow through immunosuppression; that is, they manipulate biological systems in their microenvironments and signal to a specific set of immune cells--those that clear out aberrant cells--to stop acting. It is no wonder that immunotherapy designed to re-establish anti-tumor immunity is rapidly becoming the treatment of choice for these cancers.

2 Jul 2021

New statement addresses current controversies and evolving concepts in thyroid cancer care

The American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and Molecular Imaging released a joint statement on three key topics addressing controversies in thyroid cancer care.

25 Jun 2021

New platform can detect microRNA-205 with high sensitivity, excellent selectivity

In a paper published in NANO, a team of researchers from Jiangnan University, China have prepared a convenient sensing platform which can detect microRNA-205 (MiR-205) with high sensitivity and excellent selectivity using TpTta-COF nanosheet and fluorescent oligonucleotide probes.

18 Jun 2021

Positron emission tomography can accurately measure effects of COVID-19 on the brain

The effects of COVID-19 on the brain can be accurately measured with positron emission tomography (PET), according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting.

17 Jun 2021

Novel biomarker effectively detects Alzheimer's disease before symptoms emerge

A newly developed radiotracer can measure increases in brain tau at least a year prior to the emergence of other symptoms.

15 Jun 2021

Super-resolution imaging technique could enable early detection of neurological disorders

A new imaging technique has the potential to detect neurological disorders--such as Alzheimer's disease--at their earliest stages, enabling physicians to diagnose and treat patients more quickly.

13 Jun 2021

PET radiotracer can noninvasively identify and monitor pulmonary fibrosis

Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

13 Jun 2021

Advanced AI technique can accurately predict major adverse cardiac events

An advanced artificial intelligence technique known as deep learning can predict major adverse cardiac events more accurately than current standard imaging protocols, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

13 Jun 2021

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass.

11 Jun 2021

New biomarker could be used to determine resistance of ovarian cancer to platinum chemotherapy

Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards.

28 May 2021

Molecular Imaging News and Research

Detailed performance evaluation of the uEXPLORER total-body PET/CT scanner

Molecular imaging can improve therapeutic management of pancreatic ductal adenocarcinomas

New PET imaging method tracks immunotherapeutic efficacy in mouse models

New statement addresses current controversies and evolving concepts in thyroid cancer care

New platform can detect microRNA-205 with high sensitivity, excellent selectivity

Positron emission tomography can accurately measure effects of COVID-19 on the brain

Novel biomarker effectively detects Alzheimer's disease before symptoms emerge

Super-resolution imaging technique could enable early detection of neurological disorders

PET radiotracer can noninvasively identify and monitor pulmonary fibrosis

Advanced AI technique can accurately predict major adverse cardiac events

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

New biomarker could be used to determine resistance of ovarian cancer to platinum chemotherapy

PET imaging can enable accurate diagnosis of recurring brain metastases

UVA's imaging approach could help identify brain surgery targets to stop epilepsy seizures

Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy

Novel PET tracer is safe and can clearly identify early stages of rheumatoid arthritis

Novel PET radiopharmaceutical shows promising results in first-in-humans study

Researchers develop broadly neutralizing SARS-CoV-2 ferritin nanoparticle vaccine

Scientists develop new diagnostic procedure for pulmonary aspergillosis

New treatment for late-stage neuroendocrine tumors found to be more effective and less toxic

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News